Abstract
Normal angiogenesis is self-limiting and strictly regulated while tumor angiogenesis appears to be deregulated. Angiogenesis proceeds upon a balance of angiogenic factors and inhibitors, with which expression of plasminogen activator (PA) and its inhibitor is closely associated. Angiogenic factors such as fibroblast growth factors, epidermal growth factor/transforming growth factor (TGF)-α, and vascular endothelial growth factor induce cell migration, tubulogenesis, and PA. By contrast) anti-angiogenic factors such as TGF-β and tumor necrosis factor-α inhibit cell migration tubulogenesis and expression of PA. In this article, we discuss how such angiogenic factors and anti-angiogenic factors modulate angiogenesis in model systems.
Original language | English |
---|---|
Pages (from-to) | 113-125 |
Number of pages | 13 |
Journal | Gann Monographs on Cancer Research |
Volume | 42 |
Publication status | Published - 1994 |
Externally published | Yes |
All Science Journal Classification (ASJC) codes
- Cancer Research